Inventor · disambiguated record
Stefan Berg
Also filed as: BERG STEFAN
31 granted patents·29 pending applications·232 citations·filing 1996–2010
97Inventor score
Top patents by PatentIndex Score
60 records- 0182US7855213B2CompoundsASTRAZENECA AB·Filed 2007·Granted Dec 21, 2010·7 cites·16 claims
- 0282US7595319B2Compounds having selective inhibiting effect at GSK3ASTRAZENECA AB·Filed 2003·Granted Sep 29, 2009·15 cites·3 claims
- 0381US8492584B2Process and apparatus for oxidizing organic compoundsTELES JOAQUIM HENRIQUE·Filed 2008·Granted Jul 23, 2013·5 cites·20 claims
- 0478US7585853B2Compounds having selective inhibiting effect at GSK3ASTRAZENECA AB·Filed 2003·Granted Sep 8, 2009·9 cites·2 claims
- 0577US7399780B23-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3ASTRAZENECA AB·Filed 2003·Granted Jul 15, 2008·12 cites·15 claims
- 0676US7205314B2Compounds for the treatment of dementia related diseasesASTRAZENECA AB·Filed 2002·Granted Apr 17, 2007·12 cites·8 claims
- 0774US7342022B2Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3ASTRAZENECA AB·Filed 2002·Granted Mar 11, 2008·9 cites·1 claims
- 0874US6384225B1Intermediates in the preparation of substituted chroman derivativesASTRAZENECA AB·Filed 2000·Granted May 7, 2002·7 cites·3 claims
- 0972US7078410B22-arylamino-pyrimidines for the treatment of GSK3-related disordersASTRAZENECA AB·Filed 2002·Granted Jul 18, 2006·7 cites·10 claims
- 1072US6838061B1Reactor for carrying out gas-liquid, liquid, liquid-liquid or gas-liquid-solid chemical reactionsBASF AG·Filed 1999·Granted Jan 4, 2005·36 cites·9 claims
- 1170US7595321B2Compounds having selective inhibiting effect at GSK3ASTRAZENECA AB·Filed 2003·Granted Sep 29, 2009·4 cites·7 claims
- 1269US7056939B24-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3)ASTRAZENECA AB·Filed 2002·Granted Jun 6, 2006·4 cites·10 claims
- 1367US6291458B1Morpholinobenzamide saltsASTRAZENECA AB·Filed 2000·Granted Sep 18, 2001·3 cites·20 claims
- 1466US5726321AProcess for carrying out gas/liquid reactions under avoidance of a continuous gas phaseBASF AG·Filed 1996·Granted Mar 10, 1998·11 cites·12 claims
- 1565US6479497B1Substituted chroman derivativesASTRAZENECA AB·Filed 1998·Granted Nov 12, 2002·16 cites·11 claims
- 1665US6159971ACombination of a 5-HT reuptake inhibitor and a h5-HT1B anatagonist or partial agonistASTRAZENECA AB·Filed 1998·Granted Dec 12, 2000·26 cites·23 claims
- 1763US6387899B1Substituted chroman derivativesASTRAZENECA AB·Filed 1998·Granted May 14, 2002·18 cites·27 claims
- 1862US7683067B23-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)ASTRAZENECA AB·Filed 2004·Granted Mar 23, 2010·1 cites·9 claims
- 1962US7056921B2Substituted chroman derivativesASTRAZANECA AB·Filed 2003·Granted Jun 6, 2006·2 cites·11 claims
- 2062US6410530B1Substituted 1,2,3,4-tetrahydronaphthalene derivativesASTRAZENECA AB·Filed 2000·Granted Jun 25, 2002·1 cites·30 claims
- 2161US7345050B2Pyrimidine compoundsASTRAZENECA AB·Filed 2002·Granted Mar 18, 2008·1 cites·5 claims
- 2260US7384943B2Substituted chroman derivativesASTRAZENECA AB·Filed 2006·Granted Jun 10, 2008·0 cites·13 claims
- 2360US2010087396A1Novel Compounds Having Selective Inhibiting Effect at GSK3BERG STEFAN·Filed 2009·Application pending·0 cites
- 2460US2010081660A1Novel Compounds Having Selective Inhibiting Effect at GSK3BERG STEFAN·Filed 2009·Application pending·0 cites
- 2560US2010075989A1Novel Compounds Having Selective Inhibiting Effect at GSK3ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 2659US7439356B2Substituted indan derivativesASTRAZENECA AB·Filed 2006·Granted Oct 21, 2008·0 cites·3 claims
- 2757US2009312322A1Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2855US2005096326A1Substituted indian derivativesFiled 2004·Application pending·0 cites
- 2954US6670359B2Substituted chroman derivativesASTRAZENECA AB·Filed 2002·Granted Dec 30, 2003·0 cites·13 claims
- 3054US2009149460A1New CompoundsBERG STEFAN·Filed 2008·Application pending·0 cites
- 3152US2006194854A1New 2-substituted - 1,3-thiazole compoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3252US2003144291A1Substituted indan derivativesFiled 2003·Application pending·0 cites
- 3351US2008214560A1Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's DiseaseASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3450US6534652B2Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivativesASTRAZENECA AB·Filed 2001·Granted Mar 18, 2003·0 cites·1 claims
- 3550US6410532B2Substituted 1,2,3,4-tetrahydronaphthalene derivativesASTRAZENECA AB·Filed 2001·Granted Jun 25, 2002·0 cites·22 claims
- 3648US6159970ACombination of a monoamine oxidase inhibitor and a h5-HT1B antagonist or partial agonistASTRAZENECA AB·Filed 1998·Granted Dec 12, 2000·7 cites·23 claims
- 3748US6124283ASubstituted 1,2,3,4-tetrahydronaphthalene derivativesASTRA AB·Filed 1997·Granted Sep 26, 2000·7 cites·29 claims
- 3848US2005119321A12-substituted-1,3-thiazole compoundsFiled 2003·Application pending·0 cites
- 3947US2008161269A1Compounds 620ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 4047US2008176862A1New Compounds 617ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 4146US6159972ACombination of a selective 5-HT1A antagonist and a selective ub. h5-HT.s1B antagonist or partial agonistASTRAZENECA AB·Filed 1998·Granted Dec 12, 2000·6 cites·25 claims
- 4246US2005070559A1Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3Filed 2002·Application pending·0 cites
- 4346US2010298340A1Thiazol-Guanidine Derivatives Useful As A (Beta)-Related PathologiesASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 4444US2008058349A1New Compounds 318ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 4544US2007299087A1New Compounds 319ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 4644US2008214577A1New Compounds 320ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 4744US2008051420A1New Compounds 317ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 4843US6313118B1Substituted 1,2,3,4-tetrahydronaphthalene derivativesASTRA AB·Filed 1998·Granted Nov 6, 2001·4 cites·23 claims
- 4943US2009233930A9Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and DementiaASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 5043US2009023762A1Substituted 2-Aminopyrimidine-4-Ones, Their Pharmaceutical Compositions And Their Use In The Treatment And/Or Prevention Of Ab-Related PathologiesASTRAZENECA AB·Filed 2006·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stefan Berg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →